Online citations, reference lists, and bibliographies.
← Back to Search

Involvement Of Inducible Nitric Oxide Synthase In Inflammation-induced Dopaminergic Neurodegeneration

M. Iravani, K. Kashefi, P. Mander, S. Rose, Peter Jenner
Published 2002 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The loss of dopaminergic neurones in the substantia nigra with Parkinson's disease may result from inflammation-induced proliferation of microglia and reactive macrophages expressing inducible nitric oxide synthase (iNOS). We have investigated the effects of the supranigral administration of lipopolysaccharide on iNOS-immunoreactivity, 3-nitrotyrosine formation and tyrosine hydroxylase-immunoreactive neuronal number, and retrogradely labelled fluorogold-positive neurones in the ventral mesencephalon in male Wistar rats. Following supranigral lipopolysaccharide injection, 16-18 h previously, there was intense expression of NADPH-diaphorase and iNOS-immunoreactivity in non-neuronal, macrophage-like cells. This was accompanied by intense expression of glial fibrillary acidic protein-immunoreactive astrocytosis in the substantia nigra. There were also significant reductions in the number of tyrosine hydroxylase(50-60%)- and fluorogold (65-75%)-positive neurones in the substantia nigra. In contrast, tyrosine hydroxylase-immunoreactivity in the ventral tegmental area was not altered. Pre-treatment of animals with the iNOS inhibitor, S-methylisothiourea (10 mg kg(-1), i.p.), led to a significant reduction of lipopolysaccharide-induced cell death. Similar reduction of tyrosine hydroxylase-immunoreactivity and fluorogold-labelled neurones in the substantia nigra following lipopolysaccharide administration suggests dopaminergic cell death rather than down-regulation of tyrosine hydroxylase. We conclude that the expression of iNOS- and 3-nitrotyrosine-immunoreactivity and reduction of cell death by S-methylisothiourea suggest the effects of lipopolysaccharide may be nitric oxide-mediated, although other actions of lipopolysaccharide (independent of iNOS induction) cannot be ruled out.
This paper references
10.1073/PNAS.87.4.1620
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
J. Beckman (1990)
10.1111/j.1471-4159.1988.tb10572.x
Effects of Systemic Administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine to Mice on Tyrosine Hydroxylase, l‐3,4‐Dihydroxyphenylalanine Decarboxylase, Dopamine β‐Hydroxylase, and Monoamine Oxidase Activities in the Striatum and Hypothalamus
M. Mogi (1988)
Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
B. Liu (2000)
10.1046/j.1471-4159.1999.0732469.x
Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures
K. McNaught (1999)
10.1002/JNR.490200202
Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions
H. Akiyama (1988)
10.1016/S0006-8993(99)01166-X
Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase
Robert J. Ferrante (1999)
10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N
Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
S. Murphy (2000)
10.1007/BF00689592
Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
P. L. McGeer (2004)
10.1002/(SICI)1098-2396(199707)26:3<301::AID-SYN11>3.0.CO;2-Y
Nitric oxide synthase inhibition and MPTP‐induced toxicity in the common marmoset
G. M. Mackenzie (1997)
10.1016/0028-3908(94)90045-0
Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
V. Dawson (1994)
10.1046/j.1471-4159.1995.64020936.x
Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in Mice
J. Schulz (1995)
10.1046/j.1471-4159.1997.68062227.x
Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases
J. Bolaños (1997)
10.1046/j.1471-4159.2001.00111.x
Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over‐activation by LPS
R. C. Chang (2001)
10.1111/j.1471-4159.1990.tb01962.x
Effects of 1‐Methyl‐4‐Phenyl‐ 1,2,3,6‐Tetrahydropyridine and 1 ‐Methyl‐4‐Phenylpyridinium Ion on ATP Levels of Mouse Brain Synaptosomes
Kevin P. Scotcher (1990)
10.1038/375408A0
Altered immune responses in mice lacking inducible nitric oxide synthase
X. Wei (1995)
10.1523/JNEUROSCI.20-16-06309.2000
Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia
W. G. Kim (2000)
10.1093/BRAIN/122.8.1421
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
P. Damier (1999)
10.1016/0306-4522(95)00578-1
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
S. Hunot (1996)
10.1002/ANA.410440715
Mitochondrial dysfunction in parkinson's disease
Y. Mizuno (1998)
10.1016/0165-2478(91)90022-3
The CNS acute inflammatory response to excitotoxic neuronal cell death.
P. Andersson (1991)
10.1523/JNEUROSCI.19-09-03440.1999
FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells
S. Hunot (1999)
10.1111/j.1476-5381.1995.tb13256.x
Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity
G. Southan (1995)
10.1146/ANNUREV.PH.57.030195.003513
Nitric oxide: pathophysiological mechanisms.
S. Gross (1995)
10.1002/ANA.410440712
Understanding cell death in parkinson's disease
P. Jenner (1998)
10.1016/0006-8993(95)01189-7
Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
D. Bronstein (1995)
10.1097/00001756-199508000-00013
Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease
G. Qureshi (1995)
10.1016/0166-2236(93)90109-Y
Synthesis of nitric oxide in CNS glial cells
S. Murphy (1993)
10.1046/j.1471-4159.2000.0742213.x
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
T. Dehmer (2000)
10.1016/0896-6273(94)90362-X
Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS
Sandra I. Hewett (1994)
10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4
Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: In vitro and in vivo studies
H. Possel (2000)
10.1006/nbdi.2000.0289
The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System
A. Herrera (2000)
10.1006/exnr.1996.6406
S-Methylthiocitrulline, a Neuronal Nitric Oxide Synthase Inhibitor, Protects against Malonate and MPTP Neurotoxicity
R. Matthews (1997)
10.1002/MDS.870131304
Physiology and Anatomy of Possible Oscillators in the Central Nervous System
J. Rothwell (1998)
10.1046/j.1471-4159.1998.70041584.x
Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System
A. Castaño (1998)
10.1016/S0005-2728(98)00168-6
Nitric oxide, mitochondria and neurological disease.
S. Heales (1999)
10.1016/0306-4522(92)90184-4
Histochemical mapping of nitric oxide synthase in the rat brain
S. Vincent (1992)
10.1212/WNL.38.8.1285
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
P. Mcgeer (1988)
10.1096/fasebj.6.12.1381691
Nitric oxide as a secretory product of mammalian cells
C. Nathan (1992)
10.1016/0014-5793(94)00722-5
Evidence for nitric oxide‐mediated oxidative damage in chronic inflammation Nitrotyrosine in serum and synovial fluid from rheumatoid patients
H. Kaur (1994)
10.1016/S0162-3109(98)00022-8
Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
M. Kohutnicka (1998)
10.1016/S0197-4580(99)00066-4
Increased microglial activation and protein nitration in white matter of the aging monkey☆
J. Sloane (1999)
10.1006/NBDI.1997.0141
MPP+Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice
R. Matthews (1997)
10.1038/NM0996-1017
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
P. Hantraye (1996)
10.1046/j.1471-4159.1998.71010302.x
Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies
L. Lyras (1998)
10.3109/13550289609146886
Glia: the not so innocent bystanders.
C. Chao (1996)
10.1073/PNAS.95.13.7659
Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
J. Ara (1998)
10.1002/ANA.410440717
Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?
E. Hirsch (1998)
10.1093/BRAIN/122.8.1437
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
P. Damier (1999)
10.1212/WNL.47.6_Suppl_3.161S
Oxidative stress and the pathogenesis of Parkinson's disease
P. Jenner (1996)
10.1016/c2009-0-63235-9
The Rat Brain in Stereotaxic Coordinates
G. Paxinos (1983)
10.1038/70978
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
G. Liberatore (1999)



This paper is referenced by
10.1016/j.neuint.2006.04.010
Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms
R. Pannu (2006)
10.1201/9780203503317-10
Genetic and Toxicological Models of Neurodegenerative Diseases: Stepping Stones Toward Finding a Cure
S. Bondy (2004)
10.1007/s12264-008-0066-x
Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo
Cheng-Fang Huang (2008)
10.4061/2011/487450
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
K. U. Tufekci (2011)
10.1016/S0006-8993(02)03280-8
Aberrant expression of NOS isoforms in Alzheimer’s disease is structurally related to nitrotyrosine formation
H. Lüth (2002)
10.1007/s00401-006-0086-4
Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
E. Knyihár-csillik (2006)
10.1007/978-981-10-1711-7
Inflammation: the Common Link in Brain Pathologies
N. Jana (2016)
10.1002/jbt.20384
Neurodegeneration by activated microglia across a nanofiltration membrane
D. J. Graber (2012)
10.1007/s12640-009-9045-x
Effect of Microglia Activation on Dopaminergic Neuronal Injury Induced by Manganese, and Its Possible Mechanism
Mingchao Liu (2009)
10.1016/J.JFF.2018.04.018
Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model
Bingxu Huang (2018)
10.1038/sj.bjp.0706019
Locomotor effects of imidazoline I2‐site‐specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6‐hydroxydopamine lesion of the nigrostriatal pathway
N. Macinnes (2004)
10.3844/AJBBSP.2008.146.166
A Novel Rodent Model of Autism: Intraventricular Infusions of Propionic Acid Increase Locomotor Activity and Induce Neuroinflammation and Oxidative Stress in Discrete Regions of Adult Rat Brain
D. MacFabe (2008)
10.1248/BPB.B13-00537
Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury.
Ji-Hi Pyo (2013)
10.2741/s232
Neuroinflammation and cell therapy for Parkinson's disease.
F. Li (2011)
10.3727/096368908784423328
Neuroinflammation and Peripheral Immune Infiltration in Parkinson's Disease: An Autoimmune Hypothesis
Angela J Monahan (2008)
10.3233/JAD-2008-15314
Antioxidants in central nervous system diseases: preclinical promise and translational challenges.
C. Kamat (2008)
10.1111/j.1471-4159.2006.03752.x
Nitric oxide‐producing microglia mediate thrombin‐induced degeneration of dopaminergic neurons in rat midbrain slice culture
H. Katsuki (2006)
10.1089/ARS.2005.7.1223
Oxidative and antioxidative potential of brain microglial cells.
R. Dringen (2005)
10.1016/J.BRAINRESREV.2007.02.001
Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide
S. Singh (2007)
10.1096/fj.03-0501fje
Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide
M. C. Morale (2004)
10.1111/j.1471-4159.2009.06171.x
Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling
H. Katsuki (2009)
10.1007/s10495-006-6715-5
Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway
J. Chen (2006)
10.1016/j.jneuroim.2012.03.010
Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression
M. Sadeghian (2012)
10.1155/2016/5076740
TLR4 Signaling in MPP+-Induced Activation of BV-2 Cells
Peng Zhou (2016)
10.1016/j.mad.2005.01.008
Proteasomal activity in brain differs between species and brain regions and changes with age
B. Zeng (2005)
10.1016/J.TAAP.2003.12.022
Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats.
K. Goralski (2004)
10.1007/s12640-013-9392-5
The Role of Autophagy Dysregulation in Manganese-Induced Dopaminergic Neurodegeneration
J. Zhang (2013)
10.1016/j.neuint.2013.09.021
Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA
E. Lorenc-Koci (2013)
10.1007/s00210-011-0710-2
Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease
Wu-Fu Chen (2011)
10.1016/j.nbd.2009.11.004
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
M. Tansey (2010)
10.1016/J.BCP.2007.06.016
Heme oxygenase-1 mediates cytoprotective effects of immunostimulation in microglia.
Shinrye Lee (2007)
10.2741/E726
Nitric oxide, a new player in L-DOPA-induced dyskinesia?
E. Del-Bel (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar